1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Vincent Haufroid, PharmD, PhD, is affiliated with the Department of Clinical Chemistry and the Louvain Centre for Toxicology and Applied Pharmacology at Université Catholique de Louvain in Brussels, Belgium. His publications focus on clinical toxicology and pharmacogenetics, including studies on trazodone overdose treatment and the role of cytochrome 2D6 polymorphism in serotonin toxicity recurrence. He has collaborated frequently with Philippe Hantson, Brieuc Volon, Gauthier Nendumba, Lidvine Boland, and Pierre-François Laterre.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
